Dr. Davis closed his message by expressing hope and confidence in the future-both for the graduating class of 2025 and for ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

Currently, doctors sometimes use a drug called spironolactone to treat this condition. It’s a medication that’s been around ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.

To curb the rising tide of chronic kidney disease (CKD) deaths in Ghana, a state-of-the-art kidney dialysis centre valued at ...

Novartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal ...

The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...